All Trans Retinoic Acid and Cancer

Reference

• Gropper SS, Smith JL, Groff JL. Advanced Nutrition and Human Metabolism 5th Edition, 2009: 373–1182.
   Google Scholar
• Lotan R. Retinoids as modulators of tumor cells invasion and metastasis. Semin Cancer Biol 1991; 2: 197–208.
   PubMedGoogle Scholar
• Hofmann SL. Retinoids–‘’differentiation agents’’ for cancer treatment and prevention. Am J Med Sci 1992; 304: 202–13.
   PubMedGoogle Scholar
• McBurney MW, Costa S, Pratt MA. Retinoids and cancer: a basis for differentiation therapy. Cancer Invest 1993; 11: 590–8.
   PubMed Web of Science ®Google Scholar
• Fanjul AN, Delia D, Pierotti MA, Rideout D, Yu JQ, Pfahl M. 4-Hydroxyphenyl retinamide is a highly selective activator of retinoid receptors. J Biol Chem 1996; 271: 22441–6.
   PubMed Web of Science ®Google Scholar
• Lokshin A, Zhang H, Mayotte J, Lokshin M, Levitt ML. Early effects of retinoic acid on proliferation, differentiation and apoptosis in nonsmall cell lung cancer cell lines. Anticancer Res 1999; 19: 5251–4.
   PubMed Web of Science ®Google Scholar
• Huang ME, Ye YC, Chen SR, Chai JR, Lu JX, Zhoa L, Gu LJ, Wang ZY. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 1988; 72: 567–572.
   PubMed Web of Science ®Google Scholar
• Castaigne S, Chomienne C, Daniel MT, Ballerini P, Berger R, Fenaux P, Degos L. All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia: I. Clinical results. Blood 1990; 76: 1704–1709.
   PubMed Web of Science ®Google Scholar
• Kim DG, Jo BH, You KR, Ahn DS. Apoptosis induced by retinoic acid in Hep3B cells in vitro. Cancer Lett 1996; 107: 149–159.
   PubMed Web of Science ®Google Scholar
• Hayashi K, Yokozaki H, Naka K, Yasui W, Lotan R, Tahara E. Overexpression of retinoic acid receptor β induces growth arrest and apoptosis in oral cancer cells. Jpn J Cancer Res 2001; 92: 42–50.
   PubMedGoogle Scholar
• Choi Y, Kim SY, Kim SH, Yang J, Park K, Byun Y. Inhibition of tumor growth by biodegradable microspheres containing all-trans-retinoic acid in a human head-and-neck cancer xenograft. Int J Cancer 2003; 107: 145–148.
   PubMed Web of Science ®Google Scholar
• Lee YF, Bao BY, Chang C. Modulation of the retinoic acid-induced cell apoptosis and differentiation by the human TR4 orphan nuclear receptor. Biochem Biophys Res Commun 2004; 323: 876–883.
   PubMed Web of Science ®Google Scholar
• Di C, Liao S, Adamson DC, Parrett TJ, Broderick DK, Shi Q, Lengauer C, Cummins JM, Velculescu VE, Fults DW, McLendon RE, Bigner DD, Yan H. Identification of OTX2 as a medulloblastoma oncogene whose product can be targeted by all-trans retinoic acid. Cancer Res 2005; 65: 919–924.
   PubMed Web of Science ®Google Scholar
• Edgar W: “Steroid/Thyroid Hormone Receptors”. Gene Regulation in Eukaryotes. New York: VCH: 1993;316.
   Google Scholar
• Holland LZ. “,Developmental biology: A chordate with a difference”. Nature 2007; 447: 153–155.
   PubMedGoogle Scholar
• DiSepio D, Ghosn C, Eckert RL, Deucher A, Robinson N, Duvic M, Chandraratna RA, Nagpal S. Identification and characterization of a retinoid-induced class II tumor suppressor/growth regulatory gene. Proc Natl Acad Sci U. S. A. 1998; 95: 14811–14815.
   PubMed Web of Science ®Google Scholar
• Deucher A, Nagpal S, Chandraratna RA, DiSepio D, Robinson NA, Dashti SR, Eckert RL. The carboxy-terminal hydrophobic domain of TIG3, a class II tumor suppressor protein, is required for appropriate cellular localization and optimal biological activity. Int J Oncol 2000; 17: 1195–1203.
   PubMedGoogle Scholar
• Higuchi E, Chandraratna RA, Hong WK, Lotan R. Induction of TIG3, a putative class II tumor suppressor gene, by retinoic acid in head and neck and lung carcinoma cells and its association with suppression of the transformed phenotype. Oncogene 2003; 22: 4627–4635.
   PubMed Web of Science ®Google Scholar
• Sommer A. Vitamin A Deficiency and Clinical Disease: An Historical Overview. J Nutr 2008; 138: 1835–1839.
   PubMed Web of Science ®Google Scholar
• Levin AA. Receptors as tools for understanding the toxicity of retinoids. Toxicol Lett 1995; 82/83: 91–97.
   Google Scholar
• Kim YW, Sharma RP, Li JK. Characterization of heterologously expressed recombinant retinoic acid receptors with natural or synthetic retinoids. J Biochem Toxicol 1994; 9: 225–234.
   PubMedGoogle Scholar
• Repa JJ, Hanson KK, Clagett-Dame M. All-trans-retinol is a ligand for the retinoic acid receptors. Proc Natl Acad Sci USA 1993; 90: 7293–7297.
   PubMed Web of Science ®Google Scholar
• Levin AA, Bosakowski T, Kazmer S, Grippo JF. 13-cis-Retinoic acid does not bind to the retinoic acid receptors alpha, beta, and gamma. Toxicologist 1992; 12:181.
   Google Scholar
• Heyman RA, Mangelsdorf DJ, Dyck JA, Stein RB, Eichele G, Evans RM, Thaller C. 9-cis-Retinoic acid is a high-affinity ligand for retinoid X receptor. Cell 1992; 68:397–406.
   PubMed Web of Science ®Google Scholar
• Creech KJ, Juchau MR. 9-cis-Retinoic acid: a direct-acting dysmorphogen. Biochem Pharmacol 1993b; 46: 709–717.
   PubMedGoogle Scholar
• Creech KJ, Schuh T, Juchau MR, Kimelman D. The retinoid X receptor ligand, 9-cis-retinoic acid, as an apparent regulator of early Xenopus development. Proc Natl Acad Sci USA 1994; 91: 3067–3071.
   PubMedGoogle Scholar
• Napoli JL. Retinoic acid biosynthesis and metabolism. FASEB J 1996; 10: 993–1001.
   PubMed Web of Science ®Google Scholar
• Zile MH, Emerick RJ, DeLuca HF. Identification of 13-cis-retinoic acid in tissue extracts and its biological activity in rats. Biochim Biophys Acta 1967; 141: 639–641.
   PubMed Web of Science ®Google Scholar
• Zile MH, Inhorn RC, DeLuca HF. Metabolism in vivo of all-trans-retinoic acid: biosynthesis of 13-cis-retinoic acid and all-trans- and 13-cis-retinoyl glucuronides in the intestinal mucosa of rat. J Biol Chem 1982; 257: 3544–3550.
   PubMed Web of Science ®Google Scholar
• Kalin JR, Starling ME, Hill DL. Disposition of all-trans-retinoic acid in mice following oral doses. Drug Metab Dispos 1981; 9: 196–201.
   PubMed Web of Science ®Google Scholar
• Sundaresan PR, Bhat PV. Ion-pair high-pressure liquid chromatography of cis-trans isomers of retinoic acid in tissues of vitamin A-sufficient rats. J Lipid Res 1982; 23: 448–455.
   PubMedGoogle Scholar
• Kojima R, Fujimori T, Kiyota N, Toriya Y, Fukuda T, Ohashi T, Sato T, Yoshizawa Y, Takeyama K, Mano H, Masushige S, Kato S. In vitro isomerization of retinoic acids: rapid isomer exchange and gene expression. J Biol Chem 1994; 269: 32700–32707.
   PubMedGoogle Scholar
• Shih TW, Shealy YF, Strother DL, Hill DL. Nonenzymatic isomerization of all-transand 13-cis-retinoids catalyzed by sulfhydryl groups. Drug Metab Dispos 1986; 14: 698–702.
   PubMed Web of Science ®Google Scholar
• Urbach J, Rando RR. Isomerization of all-trans-retinoic acid to 9-cis-retinoic acid. Biochem J 1994a; 299: 459–465.
   PubMedGoogle Scholar
• Shih TW, Lin T-H Shealy, YF, Hill DL. Nonenzymatic isomerization of 9-cis-retinoic acid catalyzed by sulfhydryl compounds. Drug Metab Dispos 1997; 25: 27–32.
   PubMedGoogle Scholar
• Urbach J, Rando RR. Thiol dependent isomerization of all-trans-retinoic acid to 9-cis-retinoic acid. FEBS Lett 1994b; 351: 429–432.
   PubMedGoogle Scholar
• Chen H, Juchau MR. Biotransformation of all-trans-retinal, 13-cis-retinal, and 9-cisretinal catalyzed by conceptal cytosol and microsomes. Biochem Pharmacol 1997; 53: 877–885.
   PubMedGoogle Scholar
• Napoli JL. Retinoic acid: its biosynthesis and metabolism. Prog Nucleic Acid Res Mol Biol 1999; 63: 139–188.
   PubMedGoogle Scholar
• Samokyszyn VM, Gall WE, Zawada G, Freyaldenhoven MA, Chen G, Mackenzie PI, Tephly TR, Radominska-Pandya A. 4-hydroxyretinoic acid, a novel substrate for human liver microsomal UDP-glucuronosyltransferase(s) and recombinant UGT2B7. J Biol Chem 2000; 275: 6908–6914.
   PubMed Web of Science ®Google Scholar
• Marill J, Cresteil T, Lanotte M, Chabot GG. Identification of human cytochrome P450s involved in the formation of all-trans-retinoic acid principal metabolites. Mol Pharmacol 2000; 58: 1341–1348.
   PubMed Web of Science ®Google Scholar
• Ray WJ, Bain G, Yao M, Gottlieb DI. CYP26, a novel mammalian cytochrome P450, is induced by retinoic acid and defines a new family. J Biol Chem 1997; 272:18702–18708.
   PubMed Web of Science ®Google Scholar
• White JA, Beckett-Jones B, Guo YD, Dilworth FJ, Bonasoro J, Jones G, Petkovich M. cDNA cloning of human retinoic acid-metabolizing enzyme (hP450RAI) identifies a novel family of cytochromes P450. J Biol Chem 1997; 272:18538–18541.
   PubMed Web of Science ®Google Scholar
• Creech KJ, Juchau MR. Xenopus laevis: A model system for the study of embryonic retinoid metabolism: III. Isomerization and metabolism of all-trans-retinoic acid and 9-cis retinoic acid and their dysmorphogenic effects in embryos during neurulation. Drug Metab Dispos 1995; 23: 1058–1071.
   PubMedGoogle Scholar
• Creech KJ, Kimelman D, Juchau MR. Xenopus laevis: A model system for the study of embryonic retinoid metabolism: I. Embryonic metabolism of 9-cis- and all-trans-retinals and retinols to their corresponding acid forms. Drug Metab Dispos 1995a; 23: 72–82.
   PubMedGoogle Scholar
• Creech KJ, Kimelman D, Juchau MR. Xenopus laevis: A model system for the study of embryonic retinoid metabolism: II. Embry-onic metabolism of all-trans-3,4-didehydroretinol to all-trans-3,4-didehydroretinoic acid. Drug Metab Dispos 1995b; 23: 83–89.
   PubMedGoogle Scholar
• Nau H. Teratogenesis, transplacental pharmacokinetics, and metabolism of some retinoids in the mouse, monkey, and human. In Retinoids: Progress in Research and Clinical Applications (Livrea M.A.and Packer L., Eds.), pp. 599–616.
   Google Scholar
• Barua AB, Gunning DB, Olson JA. Metabolism in vivo of all-trans-[11-3H] retinoic acid after an oral dose in rats. Biochem J 1991; 227: 527–531.
   Google Scholar
• Blaner WS, Olson JA. Retinol and retinoic acid metabolism. In The Retinoids: Biology, Chemistry and Medicine (Sporn M. B., Roberts A. B., Goodman D.S, Eds.), 1994; 2nd ed,229–255.
   Google Scholar
• Howard WB, Willhite CC, Omaye ST, Sharma RP. Comparative distribution, pharmacokinetics, and placental permeabilities of all-trans-retinoic acid, 13-cis-retinoic acid, all-trans-4-oxo-retinoic acid, retinyl acetate, and 9-cis-retinal in hamsters. Arch Toxicol 1989; 63: 112–120.
   PubMed Web of Science ®Google Scholar
• Pijnappel WWM, Hendriks HFJ, Folkers GE, Van den Brink CE, Dekker EJ, Edelenbosch C, Van der Saag PT, Durston AJ. The retinoid ligand 4-oxo-retinoic acid is a highly active modulator of positional specification. Nature 1993; 366: 340–344.
   PubMed Web of Science ®Google Scholar
• Gudas LJ. Retinoids and vertebrate development. J Biol Chem 1994; 269: 15399–15402.
   PubMed Web of Science ®Google Scholar
• Tate BF, Levin AA, Grippo JF. The discovery of 9-cis retinoic acid: a hormone that binds the retinoid-X receptor. Trends Endocrinol Metab 1994; 5: 189–194.
   PubMed Web of Science ®Google Scholar
• Lavau C, Dejean A. The t(15;17) translocation in acute promyelocytic leukemia. Leukemia 1994; 8: 1615–1621.
   PubMed Web of Science ®Google Scholar
• Petkovich M, Brand NJ, Krust A, Chambon P. A human retinoic acid receptor which belongs to the family of nuclear receptors. Nature 1987; 330: 444–450.
   PubMed Web of Science ®Google Scholar
• Giguere V, Ong ES, Segui P, Evans RM. Identification of a receptor for the morphogen retinoic acid. Nature 1987; 330: 624–629.
   PubMed Web of Science ®Google Scholar
• Mangelsdorf DJ, Ong ES, Dyck JA, Evans RM. Nuclear receptor that identifies a novel retinoic acid response pathway. Nature 1990; 345: 224–229.
   PubMed Web of Science ®Google Scholar
• Mangelsdorf DJ, Umesono K, Kliewer SA, Borgmeyer U, Ong ES, Evans RM. A direct repeat in the cellular retinol-binding protein type II gene confers differential regulation by RXR and RAR. Cell 1991; 66: 555–561.
   PubMed Web of Science ®Google Scholar
• Mangelsdorf DJ, Borgmeyer U, Heyman RA, Zhou JY, Ong ES, Oro AE, Kakizuka A, Evans RM. Characterization of three RXR genes that mediate the action of 9-cis retinoic acid. Genes Dev 1992; 6: 329–344.
   PubMed Web of Science ®Google Scholar
• Heyman RA, Mangelsdorf DJ, Dyck JA, Stein RB, Eichele G, Evans RM, Thaller C. 9-cis retinoic acid is a high affinity ligand for the retinoid X receptor. Cell 1992; 68: 397–406.
   PubMed Web of Science ®Google Scholar
• Chambon P. A decade of molecular biology of retinoic acid receptors. FASEB J 1996; 10: 940–954.
   PubMed Web of Science ®Google Scholar
• Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schütz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P, Evans RM. The nuclear receptor superfamily: the second decade. Cell 1995; 83: 835–839.
   PubMed Web of Science ®Google Scholar
• Napoli JL, Posch KP, Fiorella PD, Boerman MH. Physiological occurrence,biosynthesis and metabolism of retinoic acid: evidence for roles of cellular retinol-binding protein (CRBP) and cellular retinoic acid-binding protein (CRABP) in the pathway of retinoic acid homeostasis. Biomed Pharmacother 1991; 45: 131–143.
   PubMed Web of Science ®Google Scholar
• Ross AC. Cellular metabolism and activation of retinoids: roles of cellular retinoid-binding proteins. FASEB J 1993; 7: 317–327.
   PubMed Web of Science ®Google Scholar
• Donovan M, Olofsson B, Gustafson AL, Dencker L, Eriksson U. The cellular retinoic acid binding proteins. J Steroid Biochem Mol Biol 1995; 53: 459–465.
   PubMedGoogle Scholar
• Boylan JF, Gudas LJ. The level of CRABP-I expression influences the amounts and types of all-trans-retinoic acid metabolites in F9 teratocarcinoma stem cells. J Biol Chem 1992; 267: 21486–21491.
   PubMed Web of Science ®Google Scholar
• Napoli JL, Boerman M, Chai X, Zhai Y, Fiorella PD. Enzymes and binding proteins affecting retinoic acid concentrations. J Steroid Biochem Mol Biol 1995; 53: 497–502.
   PubMed Web of Science ®Google Scholar
• Warrell RP Jr, de Thé H, Wang ZY, Degos L. Acute promyelocytic leukemia. N Engl J Med 1993; 329: 177.
   PubMed Web of Science ®Google Scholar
• Degos L, Dombret H, Chomienne C, Daniel MT, Micléa JM, Chastang C, Castaigne S, Fenaux P. All-trans-retinoic acid as a differentiating agent in the treatment of acute promyelocytic leukemia. Blood 1995; 85: 2643.
   PubMed Web of Science ®Google Scholar
• Huang M E, Ye YC, Chen SR, Chai JR, Lu JX, Zhoa L, Gu LJ, Wang ZY. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 1988; 72: 567–572.
   PubMedGoogle Scholar
• Castaigne S, Chomienne C, Daniel MT, Ballerini P,Berger R, Fenaux P, Degos L. All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results. Blood 1990; 76:1704–1709.
   PubMed Web of Science ®Google Scholar
• Warrell RP Jr, Frankel SR, Miller WH Jr, Scheinberg DA, Itri LM, Hittelman WN, Vyas R, Andreeff M, Tafuri A, Jakubowski A,Janice G, Michael SG, Ethan D. Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid). N Engl J Med 1991; 324: 1385–1393.
   PubMed Web of Science ®Google Scholar
• Elliott S, Taylor K, White S, Rodwell R, Marlton P, Meagher D, Wiley J, Taylor D, Wright S, Timms P. Proof of differentiative mode of action of all-trans retinoic acid in acute promyelocytic leukemia using X-linked clonal analysis. Blood 1992; 79: 1916–1919.
   PubMed Web of Science ®Google Scholar
• Warrell RP, de The H, Wang ZY, Degos L. Acute promyelocytic leukemia. N Engl J Med 1993; 329: 177–189. (doi:10.1056/NEJM199307153290307)
   PubMed Web of Science ®Google Scholar
• Martin SJ, Bradley JG, Cotter TG. HL-60 cells induced to differentiate towards neutrophils subsequently die via apoptosis. Clin Exp Immunol 1990; 79: 448–453.
   PubMed Web of Science ®Google Scholar
• Gianni M, Ponzanelli I, Mologni L, Reichert U,Rambaldi A, Terao M, Garattini E. Retinoiddependent growth inhibition, differentiation and apoptosis in acute promyelocytic leukemia cells. Expression and activation of caspases. Cell Death Differ 2000; 7: 447–460. (doi:10.1038/sj.cdd.4400673)
   PubMed Web of Science ®Google Scholar
• Altucci L, Rossin A, Raffelsberger W, Reitmair A,Chomienne C, Gronemeyer H. Retinoic acidinduced apoptosis in leukemia cells is mediated by paracrine action of tumor-selective death ligand trail. Nat Med 2001; 7: 680–686. (doi:10.1038/89050)
   PubMed Web of Science ®Google Scholar
• Ruchaud S, Duprez E, Gendron MC, Houge G, Genieser HG, Jastorff B, Doskeland SO, Lanotte M. Two distinctly regulated events, priming and triggering, during retinoid-induced maturation and resistance of NB4 promyelocytic leukemia cell line. Proc Natl Acad Sci USA 1994; 91: 8428–8432. (doi:10.1073/pnas.91.18.8428)
   PubMed Web of Science ®Google Scholar
• Zhu J, Lallemand-Breitenbach V, de The H. Pathways of retinoic acid- or arsenic trioxide-induced PML/RARa catabolism: role of oncogene degradation in disease remission. Oncogene 2001; 20: 7257–7265. (doi:10.1038/sj.onc.1204852)
   PubMed Web of Science ®Google Scholar
• Zhu Q, Zhang JW, Zhu HQ, Shen YL, Flexor M, Jia PM, Yu Y, Cai X, Waxman S, Lanotte M, Chen SJ, Chen Z, Tong JH. Synergic effects of arsenic trioxide and cAMP during acute promyelocytic leukemia cell maturation subtends a novel signaling cross-talk. Blood 2002b; 99: 1014–1022. (doi:10.1182/blood.V99.7.2562)
   PubMed Web of Science ®Google Scholar
• Warrell RJ, de Thé H, Wang ZY et al: Medical progress: acute promyelocytic leukemia. N Engl J Med 329: 177–189, 1993.
   PubMed Web of Science ®Google Scholar
• Castaigne S, Chomienne C, Daniel MT, Ballerini P, Berger R, Fenaux P, Degos L. All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results. Blood 1990; 76: 1704–1709.
   PubMed Web of Science ®Google Scholar
• Warrell RJ, Frankel SR, Miller WJ et al. Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid). N Engl J Med 324: 1385–1393, 1991.
   PubMed Web of Science ®Google Scholar
• Golomb HM, Rowley J, Vardiman J et al: Partial deletion of long arm of chromosome 17: a specific abnormality in acute pro-myelocytic leukemia? Arch Intern Med 136: 825–828, 1976.
   PubMedGoogle Scholar
• Rowley JD, Golomb HM, Dougherty C. 15/17 translocation, a consistent chromosomal change in acute promyelocytic leukaemia (letter). Lancet 1977; 1: 549–550.
   PubMed Web of Science ®Google Scholar
• Mattei MG, Petkovich M, Mattei JF, Brand N, Chambon P. Mapping of the human retinoic acid receptor to the q21 band of chromosome 17. Hum Genet 1988; 80: 186–188.
   PubMed Web of Science ®Google Scholar
• Chomienne C, Ballerini P, Balitrand N et al: The retinoic acid receptor alpha gene is rearranged in retinoic acid-sensitive promyelocytic leukemias. Leukemia 4: 802–807, 1990.
   PubMed Web of Science ®Google Scholar
• de Thé H, Chomienne C, Lanotte M et al: The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor alpha gene to a novel transcribed locus. Nature 347: 558–561, 1990.
   PubMed Web of Science ®Google Scholar
• Borrow J, Goddard AD, Sheer D, Solomon E. Molecular analysis of acute promyelocytic leukemia breakpoint cluster region on chromosome 17. Science 1990; 249: 1577–1580.
   PubMed Web of Science ®Google Scholar
• Goddard AD, Borrow J, Freemont PS et al: Characterization of a zinc finger gene disrupted by the t(15;17) in acute promyelocytic leukemia. Science 254: 1371–1374, 1991.
   PubMed Web of Science ®Google Scholar
• Kakizuka A, Miller WH Jr, Umesono K, Warrell RP Jr, Frankel SR, Murty VV, Dmitrovsky E, Evans RM. Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML. Cell 1991; 66: 663–674.
   PubMed Web of Science ®Google Scholar
• Early E, Dmitrovsky E: Acute promyelocytic leukemia: retinoic acid response and resistance. J Invest Med 1995; 43: 337–344.
   PubMedGoogle Scholar
• Rousselot P, Hardas B, Patel A et al: The PML-RAR alpha gene product of the t(15;17) translocation inhibits retinoic acid-induced granulocytic differentiation and mediated transactivation in human myeloid cells. Oncogene 9: 545–551, 1994.
   PubMed Web of Science ®Google Scholar
• Breitman TR, Collins SJ, Keene BR. Terminal differentiation of human promyelocytic leukemic cells in primary culture in response to retinoic acid. Blood 1981; 57: 1000–4.
   PubMed Web of Science ®Google Scholar
• Warrell RP, Frankel SR, Miller WH, Scheinberg DA, Itri LM, Hittelman WN, Vyas R, Andreeff M, Tafuri A, Jakubowski A, Gabrilove J, Gordon MS, Dmitrovsky E. Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid). N Engl J Med 1991; 324: 1385–93.
   PubMed Web of Science ®Google Scholar
• Slack JL. Biology and treatment of acute progranulocytic leukemia. Curr Opin Hematol 1999; 6: 236–40.
   PubMedGoogle Scholar
• Grignani F, De Matteis S, Nervi C, Tomassoni L, Gelmetti V, Cioce M, Fanelli M, Ruthardt M, Ferrara FF, Zamir I, Seiser C, Grignani F, Lazar MA, Minucci S, Pelicci PG. Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia. Nature 1998; 391: 815–8.
   PubMed Web of Science ®Google Scholar
• Grunstein M. Histone acetylation in chromatin structure and transcription. Nature 1997; 389: 349–52.
   PubMed Web of Science ®Google Scholar
• Heinzel T, Lavinsky RM, Mullen TM, SOderstrom M, Laherty CD, Torchia J, Yang WM, Brard G, Ngo SD, Davie JR, Seto E, Eisenman RN, Rose DW, Glass CK, Rosenfeld MG. A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression. Nature 1997; 387: 43–8.
   PubMed Web of Science ®Google Scholar
• Kouzarides T. Histone acetylases and deacetylases in cell proliferation. Curr Opin Genet Dev 1999; 9: 40–8.
   PubMed Web of Science ®Google Scholar
• Collingwood TN, Urnov FD, Wolffe AP: Nuclear receptors. coactivators, corepressors and chromatin remodeling in the control of transcription. J Mol Endocrinol 1999; 23: 255–75.
   PubMed Web of Science ®Google Scholar
• Glass CK, Rosenfeld MG, Rose DW, Kurokawa R, Kamei Y, Xu L, Torchia J, Ogliastro MH, Westin S. Mechanisms of transcriptional activation by retinoic acid receptors. Biochem Soc Trans 1997; 25: 602–5.
   PubMedGoogle Scholar
• Casini T, Pelicci PG. A function of p21 during promyelocytic leukemia cell differentiation independent of CDK inhibition and cell cycle arrest. Oncogene 1999; 18: 3235–43.
   PubMed Web of Science ®Google Scholar
• Morosetti R, Park DJ, Chumakov AM, Grillier I, Shiohara M, Gombart AF, Nakamaki T, Weinberg K, Koeffler HP. A novel, myeloid transcription factor, C/EBP epsilon, is upregulated during granulocytic, but not monocytic, differentiation. Blood 1997; 90: 2591–600.
   PubMedGoogle Scholar
• Pelicano L, Li F, Schindler C, Chelbi-Alix MK. Retinoic acid enhances the expression of interferon-induced proteins. Evidence for multiple mechanisms of action. Oncogene 1997; 15: 2349–59.
   PubMed Web of Science ®Google Scholar
• Weis K, Rambaud S, Lavau C, Jansen J, Carvalho T, Carmo-Fonseca M, Lamond A, Dejean A. Retinoic acid regulates aberrant nuclear localization of PML-RAR alpha in acute promyelocytic leukemia cells. Cell 1994; 76: 345–56.
   PubMed Web of Science ®Google Scholar
• Agadir A, Cornic M, Jerome M, Menot ML, Cambier N, Gaub MP, Gourmel B, Lefebvre P, Degos L, Chomienne C. Characterization of nuclear retinoic acid binding activity in sensitive leukemic cell lines: cell specific uptake of ATRA and RAR alpha protein modulation. Biochem Biophys Res Commun 1995; 213: 112–22.
   PubMed Web of Science ®Google Scholar
• Chomienne C, Balitrand N, Ballerini P, Castaigne S, de The H, Degos L. All-trans retinoic acid modulates the retinoic acid receptor-alpha in promyelocytic cells. J Clin Invest 1991; 88: 2150–4.
   PubMed Web of Science ®Google Scholar
• Raelson JV, Nervi C, Rosenauer A, Benedetti L, Monczak Y, Pearson M, Pelicci PG, Miller WH. The PML/RAR alpha oncoprotein is a direct molecular target of retinoic acid in acute promyelocytic leukemia cells. Blood 1996; 88: 2826–32.
   PubMed Web of Science ®Google Scholar
• Yoshida H, Kitamura K, Tanaka K, Omura S, Miyazaki T, Hachiya T, Ohno R, Naoe T. Accelerated degradation of PML-retinoic acid receptor alpha (PML-RARA) oncoprotein by all-transretinoic acid in acute promyelocytic leukemia: possible role of the proteasome pathway. Cancer Res 1996; 56: 2945–8.
   PubMed Web of Science ®Google Scholar
• Mangelsdorf D J, Umesono K, Evans RM. The retinoid receptors. In The Retinoids: Biology, Chemistry and Medicine (Sporn M. B, Roberts A.B., and Goodman D.S, Eds.), 1994; 2nd ed., pp. 319–349. Raven Press, New York.
   Google Scholar
• Lotan R. Effects of vitamin A and its analogs (retinoids) on normal and neoplastic cells. Biochim Biophys Acta 1980; 605: 33–91.
   PubMed Web of Science ®Google Scholar
• Zuccari G, Carosio R, Fini A, Montaldo PG, Orienti I. Modified polyvinylalcohol for encapsulation of all-transretinoic acid in polymeric micelles. J Control Rel 2005; 103: 369–380.
   PubMed Web of Science ®Google Scholar
• Maiti TK, Ghosh KS, Debnath J, Dasgupta S. Binding of all-trans retinoic acid to human serum albumin: Fluorescence, FT-IR and circular dichroism studies. Int J Biol Macromol 2006; 38: 197–202.
   PubMedGoogle Scholar
• Kini AR, Peterson LC, Tallman MS, Lingen MW. Angiogenesis in acute promyelocytic leukemia: induction by vascular endothelial growth factor and inhibition by all-trans retinoic acid. Blood 2001; 97(12): 3919–3924.
   PubMedGoogle Scholar
• Aylsworth CF, Cullum ME, Zile MH, Welsh CW. Influence of dietary retinyl acetate on normal rat mammary gland development and on the enhancement of 7, 12-dimethylbenz[a]anthracene-induced rat mammary tumorigenesis by high levels of dietary fat. J Natl Cancer Inst 1986; 76: 339–345.
   PubMedGoogle Scholar
• Munker M, Munker R, Saxton RE, Koeffler HP. Effect of recombinant monokines, lymphokines, and other agents on clonal proliferation of human lung cancer cell lines. Cancer Res 1987; 47: 4081–4085.
   PubMed Web of Science ®Google Scholar
• Breitman TR, Selonick SE, Collins SJ. Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc. Natl Acad Sci U.S.A 1980; 77: 2936–2940.
   PubMed Web of Science ®Google Scholar
• Edward M, Gold JA, Mackie RM. Different susceptibilities of melanoma cells to retinoic acid-induced changes in melanotic expression. Biochem Biophys Res Commun 1988; 155: 773–778.
   PubMed Web of Science ®Google Scholar
• Wu S, Donigan A, Platsoucas CD, Jung W, Soprano DR, Soprano KJ. All-trans retinoic acid blocks cell cycle progression of human ovarian adenocarcinoma cells at late G-1. Exp Cell Res 1997a; 232: 277–286.
   PubMedGoogle Scholar
• Lippman SM, Kessler JF, Meyskens FL Jr. Retinoids as preventive and therapeutic anticancer agents (Part I). Cancer Treat Rep 1987a; 71: 391–405.
   PubMedGoogle Scholar
• Lippman SM, Kessler JF, Meyskens FL Jr. Retinoids as preventive and therapeutic anticancer agents (Part II). Cancer Treat Rep 1987b; 71:493–514.
   PubMedGoogle Scholar
• Hong WK, Endicott J, Itri LM, Doos W, Batsakis JG, Bell R, Fofonoff S, Byers R, Atkinson EN, Vaughan C, Toth B, Kramer Dimery, IW, Lippman SM, Skipper P, Strong S. 13-cis-Retinoic acid in the treatment of oral leukoplakia. N Engl J Med 1986; 315: 1501–1505.
   PubMed Web of Science ®Google Scholar
• Hong WK, Lippman SM, Itri LM, Karp DD, Lee JS, Byers RM, Schantz SP, Kramer AM, Lotan R, Peters LJ, Dimery IW, Brown BW, Goepfert H. Prevention of second primary tumors with Isotretinoin in squamous cell carcinoma of the head and neck. N Engl J Med 1990; 323: 795–801.
   PubMed Web of Science ®Google Scholar
• Geisen C, Denk C, Gremm B et al: High-level expression of the retinoic acid receptor β gene in normal cells of the uterine cervix is regulated by the retinoic acid receptor α and is abnormally down-regulated in cervical carcinoma cells. Cancer Res 57: 1460–7, 1997.
   PubMedGoogle Scholar
• Lotan R, Dawson MI, Zou CC, Jong L, Lotan D, Zou CP. Enhanced efficacy of combinations of retinoic acid- and retinoid X receptorselective retinoids and α-interferon in inhibition of cervical carcinoma cell proliferation. Cancer Res 1995; 55: 232–236.
   PubMedGoogle Scholar
• Surwit EA, Graham V, Droegemueller W et al: Evaluation of topically applied trans -retinoic acid in the treatment of cervical intraepithelial lesions. Am J Obstet Gynecol 1982; 143: 821–823.
   PubMed Web of Science ®Google Scholar
• Meyskens FL, Graham V, Chvapil M, Dorr RT, Alberts DS, Surwit EA. A phase I trial of h-all-trans -retinoic acid delivered via a collagen sponge and a cervical cap formild or moderate intraepithelial cervical neoplasia. J Natl Cancer Inst 1983; 71: 921–925.
   PubMed Web of Science ®Google Scholar
• Berlin Grace VM, Niranjali Devaraj S, Radhakrishnan Pillai M, Devaraj H. HPV-induced carcinogenesis of the uterine cervix is associated with reduced serum ATRA level. Gynecologic Oncology 2006; 103: 113–119.
   PubMed Web of Science ®Google Scholar
• Lippman SM, Batsakis JG, Toth BB, Weber R S, Lee JJ, Martin JW, Hays GL, Goepfert H, Hong WK. Comparison of low-dose isotretinoin with beta carotene to prevent oral carcinogenesis. N Engl J Med 1993; 328: 15–20.
   PubMed Web of Science ®Google Scholar
• An account of Mertz’s illness, retrieved 20 June.2007.
   Google Scholar
• Mohsen SE, Mckinney K and Shanti MS. Vitamin A toxicity. 2008.
   Google Scholar